Rohit Brijmohan Mantri
About Rohit Brijmohan Mantri
Data last updated:
Rohit Brijmohan Mantri is a Director at Bright Lifecare Private Limited (since 2025), Nominee Director at Symbiotec Pharmalab Limited (since 2018) and Nominee Director at Sensa Core Medical Instrumentation Private Limited (since 2025), and holds 7 more current directorships. The companies operate in Healthcare, Pharma and Financial Services. The 7 current companies with reported revenue have a combined latest revenue of ₹3,024 Cr; the largest is Bright Lifecare Private Limited at ₹1,368 Cr (FY 2025). Earlier, Rohit Brijmohan Mantri was a Nominee Director at Ganesh Consumer Products Limited (2018–2025) and Additional Director at Molbio Diagnostics Limited (2020) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bright Lifecare Private Limited U51909DL2011PTC218346 | Director | 28 Jan 2025 | 2011 | ₹1,368 Cr (FY 2025) | Active |
 Symbiotec Pharmalab Limited U24232MP2002PLC015293 | Nominee Director | 06 Dec 2018 | 2002 | ₹756 Cr (FY 2025) | Active |
 Sensa Core Medical Instrumentation Private Limited U74999TG2006PTC051992 | Nominee Director | 19 Dec 2025 | 2006 | ₹321 Cr (FY 2025) | Active |
 Megafine Pharma Private Limited U24239MH1995PTC092028 | Nominee Director | 21 Feb 2025 | 1995 | ₹310 Cr (FY 2025) | Active |
 Pathkind Diagnostics Private Limited U74999DL2016PTC306874 | Nominee Director | 26 May 2022 | 2016 | ₹246 Cr (FY 2025) | Active |
 Mo Alternative Ifsc Private Limited U67100GJ2021PTC127141 | Director | 13 Sep 2025 | 2021 | ₹21.64 Cr (FY 2025) | Active |
| Knovea Pharmaceutical Private Limited U24110MP2020PTC050978 | Nominee Director | 17 Feb 2020 | 2020 | ₹62.7 Lakh (FY 2025) | Active |
| Symbiotec Biologics Private Limited U21001MP2026PTC082197 | Nominee Director | 18 Feb 2026 | 2026 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ganesh Consumer Products Limited L15311WB2000PLC091315 | Nominee Director | 26 Sep 2018 | 2000 | ₹855 Cr (FY 2025) | Active |
 Molbio Diagnostics Limited L33125GA2000PLC002909 | Additional Director | 22 Jan 2020 | 2000 | Active | |
 Arinna Lifesciences Limited U24230GJ2013PLC076619 | Nominee Director | 03 May 2016 | 2013 | ₹72.24 Cr (FY 2025) | Active |
 Bigtec Private Limited U65192KA1996PTC020736 | Additional Director | 22 Jan 2020 | 1996 | ₹94.90 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rohit Brijmohan Mantri
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rohit Brijmohan Mantri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rohit Brijmohan Mantri
Rohit Brijmohan Mantri currently holds 10 directorships: Bright Lifecare Private Limited (Director, since 28 Jan 2025, revenue ₹1,368 Cr (FY 2025)); Symbiotec Pharmalab Limited (Nominee Director, since 06 Dec 2018, revenue ₹756 Cr (FY 2025)); Sensa Core Medical Instrumentation Private Limited (Nominee Director, since 19 Dec 2025, revenue ₹321 Cr (FY 2025)); Megafine Pharma Private Limited (Nominee Director, since 21 Feb 2025, revenue ₹310 Cr (FY 2025)); Pathkind Diagnostics Private Limited (Nominee Director, since 26 May 2022, revenue ₹246 Cr (FY 2025)); and 5 more.
Rohit Brijmohan Mantri was first appointed on 03 May 2016 as Nominee Director at Arinna Lifesciences Limited. The most recent appointment on record is 18 Feb 2026 at Symbiotec Biologics Private Limited.
The 7 current companies of Rohit Brijmohan Mantri that report revenue have a combined latest revenue of ₹3,024 Cr: Bright Lifecare Private Limited ₹1,368 Cr (FY 2025); Symbiotec Pharmalab Limited ₹756 Cr (FY 2025); Sensa Core Medical Instrumentation Private Limited ₹321 Cr (FY 2025); Megafine Pharma Private Limited ₹310 Cr (FY 2025); Pathkind Diagnostics Private Limited ₹246 Cr (FY 2025); and 2 more.
Rohit Brijmohan Mantri held 4 earlier board appointments: Ganesh Consumer Products Limited (Nominee Director, 26 Sep 2018 to 15 Oct 2025); Molbio Diagnostics Limited (Additional Director, 22 Jan 2020 to 22 Jan 2020); Arinna Lifesciences Limited (Nominee Director, 03 May 2016 to 30 Apr 2026); Bigtec Private Limited (Additional Director, 22 Jan 2020 to 22 Jan 2020).
The current boards of Rohit Brijmohan Mantri's companies include Arpit Sudhir Vinayak (Bright Lifecare Private Limited), Bharadwaj Thiruvenkata Venkatavaraghavan (Bright Lifecare Private Limited), Chirag Garg (Bright Lifecare Private Limited), Sameer Maheshwari (Bright Lifecare Private Limited), Sasha Gulu Mirchandani (Bright Lifecare Private Limited), Anil Satwani (Symbiotec Pharmalab Limited), among others.